Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
about
Transcriptional regulation of the tumor suppressor FHL2 by p53 in human kidney and liver cellsSplice Variants of Androgen Receptor and Prostate CancerBiologic and clinical significance of androgen receptor variants in castration resistant prostate cancerEmerging data on androgen receptor splice variants in prostate cancerIdentification of gene regulation patterns underlying both oestrogen- and tamoxifen-stimulated cell growth through global gene expression profiling in breast cancer cells.Constitutive activity of the androgen receptor.Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancerIdentification of novel therapeutic target genes in acquired lapatinib-resistant breast cancer by integrative meta-analysis.Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer.The FHL2 regulation in the transcriptional circuitry of human cancers.Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.Krüppel-like factor 8 induces epithelial-to-mesenchymal transition and promotes invasion of pancreatic cancer cells through transcriptional activation of four and a half LIM-only protein 2DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7.Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer.Alteration of Androgen Receptor Protein Stability by Triptolide in LNCaP Cells
P2860
Q21132015-2C6A4880-4E64-47F5-AF58-546D7FB5A5F2Q26740592-1D32B8D9-7AFD-4656-BF31-FBFFC734E89FQ26858922-BABDD534-F62B-469E-AF9A-F2A039D3E242Q28077830-B0428180-08CA-44F1-8E17-95565E50B05DQ34411166-57C97386-189C-4BE5-9A7D-467F51D577E5Q34775572-D1509C27-9128-4066-97E2-1634A24C2277Q35611347-02BA0AF8-D43B-4CD6-BA86-BCB32AB5C121Q38457923-FACC0D5B-5B2D-400B-AFBF-1292765E9B54Q38552283-5F59EBCE-8551-4410-B7DE-A7C169A494BDQ38554494-F13EB1F7-07D6-4918-A865-89080A7180FFQ38965002-70920C0F-D532-47AE-ABA4-CA282B356FF3Q41297598-04E40680-36C4-4ECA-A83C-7A7A3110D2BBQ49712140-A7E4598F-A441-4412-A032-0DD0A8D26750Q53735518-D4EBB14B-EEC6-45DA-9559-F5F8ACFD579FQ57825403-8D9A2BA5-34A2-4D76-8A23-6F0092F91CB7
P2860
Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Regulation of the transcriptio ...... ate-resistant prostate cancer.
@ast
Regulation of the transcriptio ...... ate-resistant prostate cancer.
@en
Regulation of the transcriptio ...... ate-resistant prostate cancer.
@nl
type
label
Regulation of the transcriptio ...... ate-resistant prostate cancer.
@ast
Regulation of the transcriptio ...... ate-resistant prostate cancer.
@en
Regulation of the transcriptio ...... ate-resistant prostate cancer.
@nl
prefLabel
Regulation of the transcriptio ...... ate-resistant prostate cancer.
@ast
Regulation of the transcriptio ...... ate-resistant prostate cancer.
@en
Regulation of the transcriptio ...... ate-resistant prostate cancer.
@nl
P2093
P50
P1433
P1476
Regulation of the transcriptio ...... ate-resistant prostate cancer.
@en
P2093
Absorn Sriratana
Birunthi Niranjan
Clare G Fedele
David Pook
Jennifer M Dyson
Lauren C Binge
Meagan J McGrath
Paul A Robinson
Susan Brown
P304
P356
10.1158/0008-5472.CAN-12-4520
P407
P577
2013-06-25T00:00:00Z